HAIKOU CITY, China, Sept. 10 /PRNewswire-Asia/ -- China Pharma Holdings, Inc. (NYSE Amex: CPHI) ("China Pharma" or the "Company"), a leading fully-integrated specialty pharmaceutical company in China, today announced that the Company's Chief Financial Officer, Mr. Frank Waung, has been invited to present at the Rodman & Renshaw Annual Global Investment Conference.
Rodman & Renshaw Annual Global Investment Conference will be held on September 12 - 15, 2010 at the New York Palace Hotel in New York City. Mr. Frank Waung is scheduled to make a presentation at 4:55 p.m. ET on Tuesday, September 14, 2010, and will be available to meet with investors throughout the conference.
For further details, please contact your respective institutional sales representative.
About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. is a rapidly growing specialty pharmaceutical company that develops, manufactures and markets a diversified portfolio of products focused on conditions with a high incidence and high mortality rates in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company's cost-effective, high margin business model is driven by market demand and supported by eight scalable GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding nationwide distribution network across 30 provinces, municipalities and autonomous regions. The Company's wholly owned subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd., is located in Haikou City, Hainan Province. For more information about China Pharma Holdings, Inc., please visit http://www.chinapharmaholdings.com .
